The Goldilocks mechanism of immune regulation
07 March, 2011 by Tim DeanAustralian researchers have discovered a subset of regulatory T cells that keep the immune system in a fine balance.
Why astrobiology gives hope for cancer therapy
09 February, 2011 by Tim DeanAstrobiologist Charles Lineweaver on the implications on cancer research of his recent paper suggesting cancer cells are like early multicellular life.
Cancer resembles life 1 billion years ago, say astrobiologists
08 February, 2011 by Tim DeanCancer is an evolutionary throwback, resembling early multicellular life, and flourishes when the more evolutionarily recent genes that regulate cellular cooperation fail.
Life scientists pick up Australia Day honours
27 January, 2011 by Staff WritersIt's a big day for many Australians, but Australia Day also proved a big day for many life scientists who were recipients of various honours, issued in a ceremony in Canberra yesterday.
Researchers view malaria in action for the first time
20 January, 2011 by Tim DeanUsing the latest super resolution microscopy, researchers have caught the malaria parasite invading red blood cells for the first time.
Why some cancer treatments help some but not others
17 January, 2011 by Tim DeanIt's long been a mystery why some colorectal cancer patients respond well to chemotherapy or radiotherapy while others barely respond at all.
First adult stem cells from Friedreich's Ataxia patients give hope for new treatment
14 January, 2011 by Tim DeanResearchers at the Monash Institute of Medical Research (MIMR) and the University of Melbourne have for the first time created adult induced pluripotent stem cells from patients with the rare genetic disorder, Friedreich's Ataxia.
Feature: Immune paradox
05 January, 2011 by Fiona WylieWhy is it that some HIV patients treated with antiretrovirals end up suffering from a new immunopathology? Martyn French is trying to solve this puzzling conundrum.
Feature: Cancer is a lean, mean, epigenetics machine
29 December, 2010 by Graeme O'NeillSusan Clark’s team at the Garvan Institute is revealing the complex epigenetic mechanisms that allow various cancers to stifle cellular defences.
Researchers lift the lid on placebos
24 December, 2010 by David BinningOf course even the most disappointing research student understands that the key to successfully conducting placebo-based studies is keeping your subjects in the dark.
Dairy-derived acids shown to ward off Type 2 diabetes
24 December, 2010 by Staff WritersResearchers at Harvard University have published a study showing that a group of fatty acids called trans-palmitoleate appears to be connected with decreased risk of Type 2 Diabetes.
Malaria down but not out (yet)
17 December, 2010 by Tim DeanThe WHO report on malaria shows promising reductions in infections and deaths, but scientists warn malaria might be back with a vengeance unless efforts to eradicate it aren't maintained.
Feature: Antibody attack on acute myeloid leukaemia
16 December, 2010 by Staff WritersCLS Principal Scientist, Samantha Busfield, is working on CSL’s newly developed anti-interleukin-3 (IL3) receptor antibody in the hope that it will provide a new treatment for acute myeloid leukaemia.
LCT gets green light from Russia for Type 1 diabetes treatment Diabecell
10 December, 2010 by David BinningLiving Cell Technologies (LCT) announced today that Russia has become the first country in the world to approve the use and sale of its Diabecell porcine implant for Type 1 diabetics.
Could aspirin help to prevent deaths from cancer, or even cancer itself?
07 December, 2010 by David BinningBritish researchers have published the results of a study which shows that a small dose of aspirin daily could dramatically reduce incidences of cancer related death.
